| Literature DB >> 28406434 |
Shingo Miyamoto1, Masami Komiya2, Gen Fujii3, Takahiro Hamoya4, Ruri Nakanishi5, Kyoko Fujimoto6, Shuya Tamura7, Yurie Kurokawa8, Maiko Takahashi9, Tetsuo Ijichi10, Michihiro Mutoh11,12.
Abstract
Establishing effective methods for preventing colorectal cancer by so-called "functional foods" is important because the global burden of colorectal cancer is increasing. Enterococcus faecalis strain EC-12 (EC-12), which belongs to the family of lactic acid bacteria, has been shown to exert pleiotropic effects, such as anti-allergy and anti-infectious effects, on mammalian cells. In the present study, we aimed to evaluate the preventive effects of heat-killed EC-12 on intestinal carcinogenesis. We fed 5-week-old male and female Apc mutant Min mice diets containing 50 or 100 ppm heat-killed EC-12 for 8 weeks. In the 50 ppm treated group, there was 4.3% decrease in the number of polyps in males vs. 30.9% in females, and significant reduction was only achieved in the proximal small intestine of female mice. A similar reduction was observed in the 100 ppm treated group. Moreover, heat-killed EC-12 tended to reduce the levels of c-Myc and cyclin D1 mRNA expression in intestinal polyps. Next, we confirmed that heat-killed EC-12 suppressed the transcriptional activity of the T-cell factor/lymphoid enhancer factor, a transcriptional factor involved in cyclin D1 mRNA expression in intestinal polyps. Our results suggest that heat-killed EC-12 very weakly suppresses intestinal polyp development in Min mice, in part by attenuating β-catenin signaling, and this implies that heat-killed EC-12 could be used as a "functional food".Entities:
Keywords: Min mice; colorectal cancer chemoprevention; functional foods; heat-killed EC-12; intestinal polyps
Mesh:
Substances:
Year: 2017 PMID: 28406434 PMCID: PMC5412410 DOI: 10.3390/ijms18040826
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Effect of Enterococcus faecalis strain EC-12 (EC-12) (50 ppm) on the number of polyps in Min mice.
| Dose (ppm) | Gender (Number of Mice) | Small Intestine | Colon | Total | ||
|---|---|---|---|---|---|---|
| Proximal | Middle | Distal | ||||
| 0 | Male (8) | 6.3 ± 4.3 | 9.3 ± 3.5 | 29.3 ± 7.6 | 1.8 ± 2.0 | 46.5 ± 11.6 |
| 50 | Male (10) | 6.7 ± 3.1 | 11.8 ± 6.4 | 25.7 ± 11.7 | 0.3 ± 0.7 | 44.5 ± 18.1 |
| 0 | Female (9) | 8.4 ± 5.2 | 12.2 ± 6.7 | 28.6 ± 15.5 | 0.1 ± 0.3 | 48.2 ± 19.7 |
| 50 | Female (8) | 3.8 ± 2.0 * | 10.0 ± 3.2 | 18.1 ± 11.3 | 0.8 ± 0.7 | 33.3 ± 13.9 |
Data are presented as the means ± SD. Significantly different from the untreated control group at * p < 0.05.
Effect of EC-12 (100 ppm) on the number of polyps in Min mice.
| Dose (ppm) | Gender (Number of Mice) | Small Intestine | Colon | Total | ||
|---|---|---|---|---|---|---|
| Proximal | Middle | Distal | ||||
| 0 | Male (9) | 5.3 ± 2.1 | 9.3 ± 3.2 | 23.1 ± 2.9 | 1.4 ± 2.0 | 39.2 ± 4.2 |
| 100 | Male (9) | 2.3 ± 0.9 | 6.9 ± 2.9 * | 23.7 ± 8.3 | 0.8 ± 1.6 | 33.7 ± 11.7 |
| 0 | Female (8) | 5.3 ± 2.6 | 9.4 ± 2.8 | 25.9 ± 11.1 | 1.8 ± 3.5 | 42.3 ± 10.3 |
| 100 | Female (8) | 3.1 ± 2.0 | 8.5 ± 2.8 | 17.8 ± 9.3 | 0.4 ± 0.5 | 29.8 ± 13.0 |
Data are presented as the means ± SD. Significantly different from the untreated control group at * p < 0.05.
Effect of EC-12 (50 ppm) on the size distribution of intestinal polyps in Min mice.
| Dose (ppm) | Gender | Diameter (mm) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| <0.5 | 0.5 to <1.0 | 1.0 to <1.5 | 1.5 to <2.0 | 2.0 to <2.5 | 2.5 to <3.0 | 3.0 to <3.5 | 3.5 to <4.0 | 4.0 to <4.5 | ≥4.5 | ||
| 0 | Male | 13.4 ± 6.5 | 19.6 ± 7.1 | 7.0 ± 3.0 | 3.6 ± 2.9 | 2.0 ± 2.1 | 0.3 ± 0.5 | 0.3 ± 0.5 | 0.1 ± 0.4 | 0.3 ± 0.5 | 0.0 ± 0.0 |
| 50 | Male | 12.2 ± 6.1 | 21.2 ± 10.1 | 7.0 ± 6.1 | 3.1 ± 2.4 | 0.5 ± 0.7 | 0.2 ± 0.4 | 0.2 ± 0.4 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.03 ± 0.2 |
| 0 | Female | 15.8 ± 7.2 | 23.7 ± 12.4 | 6.1 ± 4.7 | 1.6 ± 0.9 | 0.9 ± 0.8 | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| 50 | Female | 8.3 ± 4.3 * | 14.9 ± 9.1 | 5.5 ± 2.1 | 3.3 ± 3.1 | 0.9 ± 0.6 | 0.1 ± 0.4 | 0.3 ± 0.5 | 0.0 ± 0.0 | 0.1 ± 0.4 | 0.0 ± 0.0 |
Data are presented as the means ± SD. Significantly different from the untreated control group at * p < 0.05.
Effect of EC-12 (100 ppm) on the size distribution of intestinal polyps in Min mice.
| Dose (ppm) | Gender | Diameter (mm) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| <0.5 | 0.5 to <1.0 | 1.0 to <1.5 | 1.5 to <2.0 | 2.0 to <2.5 | 2.5 to <3.0 | 3.0 to <3.5 | 3.5 to <4.0 | 4.0 to <4.5 | ≥4.5 | ||
| 0 | Male | 7.2 ± 4.4 | 16.6 ± 2.8 | 8.1 ± 3.6 | 4.3 ± 1.8 | 2.1 ± 0.8 | 0.8 ± 0.8 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.1 ± 0.3 |
| 100 | Male | 3.9 ± 4.2 | 12.9 ± 4.5 | 10.4 ± 4.9 | 4.6 ± 2.0 | 1.4 ± 1.0 | 0.1 ± 0.3 | 0.2 ± 0.4 | 0.1 ± 0.3 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| 0 | Female | 9.9 ± 4.3 | 20.9 ± 7.2 | 6.1 ± 3.0 | 2.5 ± 1.1 | 1.8 ± 1.4 | 0.6 ± 0.7 | 0.3 ± 0.5 | 0.0 ± 0.0 | 0.3 ± 0.5 | 0.0 ± 0.0 |
| 100 | Female | 3.9 ± 3.6 * | 12.5 ± 7.6 * | 7.9 ± 5.1 | 3.9 ± 2.0 | 1.1 ± 1.0 | 0.4 ± 0.5 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.1 ± 0.4 | 0.0 ± 0.0 |
Data are presented as the means ± SD. Significantly different from the untreated control group at * p < 0.05.
Figure 1Effect of EC-12 (100 ppm) on the mRNA levels of cell proliferation-related factors in the intestines of Min mice. Quantitative real-time PCR anlysis was performed to determine c-Myc and cyclin D1 expression levels in the non-polyp (mucosa) and polyp portions of the intestines of female Min mice. Data were normalized to GAPDH. Each expression level in the non-polyp portions of the intestines in the control group (0 ppm) was set to one. Data are the mean ± SD, n = 5.
Figure 2Effect of EC-12 on T-cell factor/lymphoid enhancer factor (TCF/LEF) promoter transcriptional activity in HCT116 cells. HCT116-TCF/LEF-Luc cells (A) and RKO-TCF/LEF-Luc cells (B) were treated with heat-killed EC-12 for 24 h. Wnt3a-conditioned medium was added 30 min after EC-12 treatment of RKO cells. The basal luciferase activity level of the control was set to 1.0. Data are the mean ± SD (n = 4).
Figure 3Effect of EC-12 on enterobacterium in the feces of Min mice. Feces of five mice in each group were collected from the rectum of Min mice. The amount of the indicated bacterium was evaluated by quantitative real-time PCR analysis. The window shows an enlarged view of the Figure, especially the amount of Enterococci and the Clostridium perfringens group. Open column: control group; closed column: 100 ppm EC-12-treated group. Data are the mean ± SD (n = 5). RQ: relative quantification.